Bausch Health Cos EBIT 2010-2024 | BHC
Bausch Health Cos ebit from 2010 to 2024. Ebit can be defined as earnings before interest and taxes.
Bausch Health Cos Annual EBIT
(Millions of US $) |
| 2023 |
$963 |
| 2022 |
$454 |
| 2021 |
$450 |
| 2020 |
$676 |
| 2019 |
$-203 |
| 2018 |
$-2,384 |
| 2017 |
$102 |
| 2016 |
$-566 |
| 2015 |
$1,527 |
| 2014 |
$2,001 |
| 2013 |
$-410 |
| 2012 |
$80 |
| 2011 |
$300 |
| 2010 |
$-110 |
| 2009 |
$181 |
Bausch Health Cos Quarterly EBIT
(Millions of US $) |
| 2024-06-30 |
$389 |
| 2024-03-31 |
$281 |
| 2023-12-31 |
$362 |
| 2023-09-30 |
$14 |
| 2023-06-30 |
$412 |
| 2023-03-31 |
$175 |
| 2022-12-31 |
$-244 |
| 2022-09-30 |
$244 |
| 2022-06-30 |
$161 |
| 2022-03-31 |
$293 |
| 2021-12-31 |
$367 |
| 2021-09-30 |
$574 |
| 2021-06-30 |
$-270 |
| 2021-03-31 |
$-221 |
| 2020-12-31 |
$-5 |
| 2020-09-30 |
$460 |
| 2020-06-30 |
$-27 |
| 2020-03-31 |
$248 |
| 2019-12-31 |
$-1,076 |
| 2019-09-30 |
$329 |
| 2019-06-30 |
$257 |
| 2019-03-31 |
$287 |
| 2018-12-31 |
$25 |
| 2018-09-30 |
$117 |
| 2018-06-30 |
$-245 |
| 2018-03-31 |
$-2,281 |
| 2017-12-31 |
$-322 |
| 2017-09-30 |
$38 |
| 2017-06-30 |
$175 |
| 2017-03-31 |
$211 |
| 2016-12-31 |
$150 |
| 2016-09-30 |
$-863 |
| 2016-06-30 |
$81 |
| 2016-03-31 |
$66 |
| 2015-12-31 |
$167 |
| 2015-09-30 |
$448 |
| 2015-06-30 |
$342 |
| 2015-03-31 |
$571 |
| 2014-12-31 |
$605 |
| 2014-09-30 |
$684 |
| 2014-06-30 |
$355 |
| 2014-03-31 |
$357 |
| 2013-12-31 |
$224 |
| 2013-09-30 |
$-892 |
| 2013-06-30 |
$142 |
| 2013-03-31 |
$117 |
| 2012-12-31 |
$-98 |
| 2012-09-30 |
$29 |
| 2012-06-30 |
$87 |
| 2012-03-31 |
$61 |
| 2011-12-31 |
$-6 |
| 2011-09-30 |
$112 |
| 2011-06-30 |
$118 |
| 2011-03-31 |
$75 |
| 2010-12-31 |
$-49 |
| 2010-09-30 |
$-126 |
| 2010-06-30 |
$49 |
| 2010-03-31 |
$16 |
| 2009-12-31 |
$59 |
| 2009-09-30 |
$58 |
| 2009-06-30 |
$11 |
| 2009-03-31 |
$54 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$2.956B |
$8.757B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
